A Breakthrough in Preventing Inherited Mitochondrial Disease: Three-Parent Technology

📅 Publication Details and Scientific Context

This synthesis draws on findings released on 16 July 2025 in The New England Journal of Medicine (NEJM), which simultaneously published the following three scientific documents analyzed here:

• Original Research: Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA Disease
• Brief Clinical Report: Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease
• Editorial: Advances in Preventing Transmission of Mitochondrial DNA Diseases

💉 Mitochondrial Diseases: Definition, Examples and Frequency

Mitochondrial diseasesare inherited metabolic disorders affecting mitochondrial energy production, usually caused by maternally transmitted mitochondrial DNA (mtDNA) mutations.

Best-Known Mitochondrial Diseases:

• Leigh Syndrome
• MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes)
• LHON (Leber Hereditary Optic Neuropathy)
• MERRF (Myoclonic Epilepsy with Ragged Red Fibers)

Frequency:

• Approximately 1/4300 people have mitochondrial disease.
• One in 200 people may carry a pathogenic mtDNA variant.

Common Symptoms:

• Muscle weakness and exercise intolerance
• Cardiomyopathy
• Vision and hearing loss
• Seizures
• Developmental delay
• Encephalopathy and stroke-like episodes

Symptom severity is related to the degree of heteroplasmy.

🧬 What Is Mitochondrial Donation?

Mitochondrial donationtransfers the nucleus of a fertilized egg from an affected woman into an enucleated egg from a healthy donor.

• It is suitable for homoplasmic women, whose mtDNA is entirely affected.
• It is also preferred with high heteroplasmy levels.

⚖️ Study Scope and Design

This comparative observational study assessed two assisted reproductive technologies in women carrying mitochondrial disease, examining real-world outcomes .

A total of 61 women carrying pathogenic mitochondrial DNA (mtDNA) variants participated. They were allocated according to mutation burden (heteroplasmy level) and personal preference:

• 22 women underwent pronuclear transfer for mitochondrial donation.

• 39 women underwent preimplantation genetic testing (PGT) .

What Is PGT?

Preimplantation genetic testing (PGT)analyzes a few cells from embryos created through conventional in vitro fertilization (IVF). In women carrying mtDNA variants, it measures the proportion of mutant mitochondria (heteroplasmy). Only low-risk embryos are transferred, aiming to prevent transmission.

The research highlighted the strengths of pronuclear transfer and PGT in efficacy and safety , offering practical clinical guidance on the most suitable strategy for different patient groups.

📊 Study Data

🧬 Newborn mtDNA Levels (Heteroplasmy)

Genetic analysis of newborn blood samples measured the proportion of pathogenic mitochondrial DNA variants (% heteroplasmy), a critical marker of disease risk.

• Pronuclear Transfer In the 8 babies born through this method, heteroplasmy was: 0% – 16%
  • In 6 babies, affected mtDNA was reduced by 95% – 100% .
  • In 2 babies, the reduction ranged from 77% – 88% .
• PGT In 10 babies born after PGT, heteroplasmy was: 0% – 7%

Note: Medically, heteroplasmy below 15% is generally considered safe and unlikely to cause disease.

👶 Clinical Follow-Up and Health

Newborns underwent regular health monitoring after birth. Findings were:

• All babies were healthy at birth according to assessment.
• Only 2 babies had mild, temporary adverse effects :
  • One baby had infantile myoclonic epilepsy (resolved spontaneously without treatment).
  • In the other, a congenital heart rhythm disorder (associated with hyperlipidemia) responded fully to medical treatment.

📌 Conclusion